Mirxes Holding Files for Hong Kong IPO with Focus on miRNA Test Kits
Mirxes Holding Company Ltd, a Singapore – headquartered RNA technology company, has received a filing...
IPO
Ascentage Pharma Prices US IPO at USD 17.25 per ADS
China-based Ascentage Pharma (NASDAQ: AAPG, HKG: 6855) has announced the pricing of its initial public...
Shanghai Bao Pharmaceuticals Launches IPO to Advance Biopharmaceutical Pipeline
China-based Shanghai Bao Pharmaceuticals Co., Ltd., a high-end biopharmaceuticals developer, has announced its initial public...
Sichuan Biokin Re-submits IPO Application to Hong Kong Stock Exchange
Sichuan Biokin Pharmaceutical Co., Ltd (SHA: 688506) has announced that it has resubmitted its application...
Fujian Haixi Pharmaceuticals Files for Hong Kong IPO
China-based Fujian Haixi Pharmaceuticals Co., Ltd., a commercial-stage innovative pharmaceutical company, has made an initial...
Sepax Technologies Debuts on STAR Market with Soaring IPO Prices
Sino-US firm Sepax Technologies Co., Inc. has successfully completed its initial public offering (IPO) on...
TCMTech Files for IPO on Hong Kong Stock Exchange, Showcasing TCM AI Leadership
China-based TCMTech Inc., recognized as the largest artificial intelligence (AI) empowered traditional Chinese medicine (TCM)...
BrainAurora Medical Technology IPOs on Hong Kong Stock Exchange
Zhejiang-based BrainAurora Medical Technology Limited (HKG: 6681), the first company in China to combine neuroscience...
Mabwell Bioscience Files for IPO on Hong Kong Stock Exchange, Expanding Biopharma Reach
Mabwell (Shanghai) Bioscience Co., Ltd. (SHA: 688062) has officially filed for an initial public offering...
Hengrui Pharmaceuticals Files IPO Prospectus in Hong Kong Amid Record Deal-Making
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) has officially submitted an initial public offering (IPO)...
We Doctor Holdings Limited Files for IPO on Hong Kong Stock Exchange
China-based We Doctor Holdings Limited, a subsidiary of Chinese internet giant Tencent Corporate Venture Capital...
GenFleet Therapeutics Submits IPO Application to HKEX, Backed by CITIC Securities
On December 27, 2024, GenFleet Therapeutics, a biopharmaceutical company based in Shanghai, submitted its application...
Dynamiker Biotechnology Receives Approval for IPO on Beijing Stock Exchange
On December 27, 2024, the official website of the Beijing Stock Exchange announced that Dynamiker...
Ascentage Pharma Announces Secondary Offering on Nasdaq, Expanding Global Reach
China-based Ascentage Pharma (HKG: 6855) has unveiled plans for a secondary offering of up to...
Biopharma Company TransThera Sciences (Nanjing) Gets Green Light for HK IPO
On December 20, 2024, the China Securities Regulatory Commission confirmed the listing filing for TransThera...
iFlytek’s Subsidiary Xunfei Healthcare Technologies Lists on HKEX, Raises Over HKD 580 Million
Xunfei Healthcare Technology Co., Ltd, a subsidiary of China-based information technology company iFlytek Co., Ltd...
HealthyWay Inc. Completes HKD 220 Million IPO on the Hong Kong Stock Exchange
China-based HealthyWay Inc. (HKG: 2587) has made a significant debut on the Hong Kong Stock...
iFlytek’s Xunfei Healthcare Passes HKEX Hearing for AI-Powered Medical IPO
Xunfei Healthcare Technology Co., Ltd., a subsidiary of China’s leading information technology company iFlytek Co.,...
Mabwell Bioscience Plans Secondary Listing in Hong Kong, Secures Funding for Bone Health Project
Mabwell (Shanghai) Bioscience Co., Ltd. (SHA: 688062) is set to make a secondary listing on...
Sunshine Lake Pharma Files for HKEX IPO, Expanding Global Pharmaceutical Reach
China-based Sunshine Lake Pharma Co., Ltd has submitted an initial public offering (IPO) filing to...